SG

Sanjay Gupta

Director Director DIN 01380269
DIN 01380269 First appointment May 2003 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Gupta

Data last updated:

Sanjay Gupta was a Director at Aadimedicos Lab Private Limited (2021–2023) and Director at Intercare Pharmaceuticals Private Limited (from 2003). The companies operate in Trading.

DIN 01380269
Primary Designation Director
Industry Trading
First Appointment 14 May 2003
Oldest Company Age 23 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aadimedicos Lab Private Limited U51909UP2021PTC143489
Director15 Mar 20212021₹10.8 Lakh (FY 2025)Active
Director14 May 20032003Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Intercare Pharmaceuticals Private Limited
Aadimedicos Lab Private Limited
Premium access

Shareholding and investment profile for Sanjay Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Gupta

Sanjay Gupta was first appointed on 14 May 2003 as Director at Intercare Pharmaceuticals Private Limited. The most recent appointment on record is 15 Mar 2021 at Aadimedicos Lab Private Limited.

Sanjay Gupta held 2 earlier board appointments: Aadimedicos Lab Private Limited (Director, 15 Mar 2021 to 01 Feb 2023); Intercare Pharmaceuticals Private Limited (Director, from 14 May 2003).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available